Target intelligence / Profile preview

BAG family molecular chaperone regulator 3 (BAG3)

Target
BAG3
Molecular classification
Co-chaperone protein, Adapter protein for heat shock proteins, Protein quality control factor, Other
01

Overview

BAG family molecular chaperone regulator 3 (BAG3) is a co-chaperone protein encoded by the BAG3 gene that functions primarily in cellular protein quality control and stress responses[1][2]. BAG3 interacts with heat shock proteins such as HSP70 and HSPB8 to mediate chaperone-assisted selective autophagy, targeting aggregated or damaged proteins for degradation via the autophagic-lysosomal pathway[2]. It also bridges molecular chaperones and the cytoskeleton, ensuring cellular proteostasis, especially under mechanical or environmental stress[1]. BAG3 is expressed at high levels in muscle and is upregulated during cellular stress and in cancer[4]. Functionally, BAG3 supports cell survival by inhibiting apoptosis, promoting cell proliferation, and enabling cytoskeletal resilience. Disease relevance includes roles in cancer, neurodegeneration, cardiomyopathies, and muscle diseases[1][2][4]. Therapeutically, BAG3 has been explored as a target for modulating proteostasis in neurodegenerative disease, as well as sensitizing tumor cells to apoptosis. However, targeting BAG3 carries safety concerns due to its roles in vital homeostatic processes, especially in muscle and neural tissue[1][2][4].

Other names
BAG3BCL2 associated athanogene 3BAG cochaperone 3
02

Mechanism of action

Modulation of autophagy (especially selective macroautophagy for aggregated protein clearance)[2] Promotion of cell survival by inhibiting apoptosis (by interaction with BCL-2, HSP70, etc.)[2][4] Sensitization to apoptotic cell death when BAG3 is suppressed, notably with BH3-mimetics in cancer models[2]

03

Biological functions

Protein quality control (proteostasis)Chaperone-assisted selective autophagyAnti-apoptosisCell proliferationRegulation of cell cycleCell survival under stressCytoskeleton maintenanceSignal transduction modulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular disease (familial dilated cardiomyopathy)MyopathiesOther
05

Safety considerations

Targeting BAG3 may disrupt essential protein quality control mechanisms, potentially causing toxicity in muscle and essential cell types[1][2]Suppression may promote apoptosis in normal as well as cancerous cells, impacting cell survival[2][4]
06

Interacting drugs

BH3-mimetics (examples: venetoclax, navitoclax) [only mechanistically stated, not directly tested against BAG3]
07

Biomarkers

BAG3 protein expression as a marker of poor prognosis in certain cancers (e.g., chronic lymphocytic leukemia, melanoma)[2]

Beyond the preview

Go deeper on BAG family molecular chaperone regulator 3 (BAG3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAG family molecular chaperone regulator 3 (BAG3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call